摘要
BACKGROUND Self-expandable metal stents(SEMSs) are frequently used in the setting of palliation for occluding, inoperable colorectal cancer(CRC). Among possible complications of SEMS positioning, re-obstruction is the most frequent. Its management is controversial, potentially involving secondary stent-in-stent placement, which has been poorly investigated. Moreover, the issue of secondary stent-in-stent re-obstruction and of more-than-two colonic stenting has never been assessed. We describe a case of tertiary SEMS-in-SEMS placement, and also discuss our practice based on available literature.CASE SUMMARY A 66-year-old male with occluding and metastatic CRC was initially treated by positioning of a SEMS, which had to be revised 6 mo later when a symptomatic intra-stent tumor ingrowth was treated by a SEMS-in-SEMS. We hereby describe an additional episode of intestinal occlusion due to recurrence of intra-stent tumor ingrowth. This patient, despite several negative prognostic factors(splenic flexure location of the tumor, carcinomatosis with ascites, subsequent chemotherapy that included bevacizumab and two previously positioned stents(1 SEMS and 1 SEMS-in-SEMS)) underwent successful management through the placement of a tertiary SEMS-in-SEMS, with immediate clinical benefit and no procedure-related adverse events after 150 d of post-procedural follow-up. This endoscopic management has permitted 27 mo of partial control of a metastatic disease without the need for chemotherapy discontinuation and, ultimately, a good quality of life until death.CONCLUSION Tertiary SEMS-in-SEMS is technically feasible, and appears to be a safe and effective option in the case of recurrent SEMS obstruction.
BACKGROUND Self-expandable metal stents(SEMSs) are frequently used in the setting of palliation for occluding, inoperable colorectal cancer(CRC). Among possible complications of SEMS positioning, re-obstruction is the most frequent. Its management is controversial, potentially involving secondary stent-in-stent placement, which has been poorly investigated. Moreover, the issue of secondary stent-in-stent re-obstruction and of more-than-two colonic stenting has never been assessed. We describe a case of tertiary SEMS-in-SEMS placement, and also discuss our practice based on available literature.CASE SUMMARY A 66-year-old male with occluding and metastatic CRC was initially treated by positioning of a SEMS, which had to be revised 6 mo later when a symptomatic intra-stent tumor ingrowth was treated by a SEMS-in-SEMS. We hereby describe an additional episode of intestinal occlusion due to recurrence of intra-stent tumor ingrowth. This patient, despite several negative prognostic factors(splenic flexure location of the tumor, carcinomatosis with ascites, subsequent chemotherapy that included bevacizumab and two previously positioned stents(1 SEMS and 1 SEMS-in-SEMS)) underwent successful management through the placement of a tertiary SEMS-in-SEMS, with immediate clinical benefit and no procedure-related adverse events after 150 d of post-procedural follow-up. This endoscopic management has permitted 27 mo of partial control of a metastatic disease without the need for chemotherapy discontinuation and, ultimately, a good quality of life until death.CONCLUSION Tertiary SEMS-in-SEMS is technically feasible, and appears to be a safe and effective option in the case of recurrent SEMS obstruction.
引文
1 Siegel RL,Miller KD,Jemal A.Cancer statistics,2018.CA Cancer J Clin 2018;68:7-30[PMID:29313949 DOI:10.3322/caac.21442]
2 Bray F,Ferlay J,Soerjomataram I,Siegel RL,Torre LA,Jemal A.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CACancer J Clin 2018;68:394-424[PMID:30207593 DOI:10.3322/caac.21492]
3 van Hooft JE,van Halsema EE,Vanbiervliet G,Beets-Tan RG,DeWitt JM,Donnellan F,Dumonceau JM,Glynne-Jones RG,Hassan C,Jiménez-Perez J,Meisner S,Muthusamy VR,Parker MC,Regimbeau JM,Sabbagh C,Sagar J,Tanis PJ,Vandervoort J,Webster GJ,Manes G,Barthet MA,Repici A;European Society of Gastrointestinal Endoscopy(ESGE).Self-expandable metal stents for obstructing colonic and extracolonic cancer:European Society of Gastrointestinal Endoscopy(ESGE)Clinical Guideline.Gastrointest Endosc 2014;80:747-761.e1-e75[PMID:25436393 DOI:10.1016/j.gie.2014.09.018]
4 Jullumstr?E,Wibe A,Lydersen S,Edna TH.Colon cancer incidence,presentation,treatment and outcomes over 25 years.Colorectal Dis 2011;13:512-518[PMID:20128833 DOI:10.1111/j.1463-1318.2010.02191.x]
5 Cheynel N,Cortet M,Lepage C,Benoit L,Faivre J,Bouvier AM.Trends in frequency and management of obstructing colorectal cancers in a well-defined population.Dis Colon Rectum2007;50:1568-1575[PMID:17687610 DOI:10.1007/s10350-007-9007-4]
6 Frago R,Ramirez E,Millan M,Kreisler E,del Valle E,Biondo S.Current management of acute malignant large bowel obstruction:a systematic review.Am J Surg 2014;207:127-138[PMID:24124659 DOI:10.1016/j.amjsurg.2013.07.027]
7 Ribeiro IB,Bernardo WM,Martins BDC,de Moura DTH,Baba ER,Josino IR,Miyahima NT,Coronel Cordero MA,Visconti TAC,Ide E,Sakai P,de Moura EGH.Colonic stent versus emergency surgery as treatment of malignant colonic obstruction in the palliative setting:a systematic review and meta-analysis.Endosc Int Open 2018;6:E558-E567[PMID:29756013 DOI:10.1055/a-0591-2883]
8 Fugazza A,Galtieri PA,Repici A.Using stents in the management of malignant bowel obstruction:the current situation and future progress.Expert Rev Gastroenterol Hepatol 2017;11:633-641[PMID:28325090 DOI:10.1080/17474124.2017.1309283]
9 Sagar J.Role of colonic stents in the management of colorectal cancers.World J Gastrointest Endosc 2016;8:198-204[PMID:26962401 DOI:10.4253/wjge.v8.i4.198]
10 Zhao XD,Cai BB,Cao RS,Shi RH.Palliative treatment for incurable malignant colorectal obstructions:a meta-analysis.World J Gastroenterol 2013;19:5565-5574[PMID:24023502 DOI:10.3748/wjg.v19.i33.5565]
11 Vemulapalli R,Lara LF,Sreenarasimhaiah J,Harford WV,Siddiqui AA.A comparison of palliative stenting or emergent surgery for obstructing incurable colon cancer.Dig Dis Sci 2010;55:1732-1737[PMID:19693667 DOI:10.1007/s10620-009-0945-7]
12 Súarez J,Jiménez J,Vera R,Tarifa A,Balén E,Arrazubi V,Vila J,Lera JM.Stent or surgery for incurable obstructive colorectal cancer:an individualized decision.Int J Colorectal Dis 2010;25:91-96[PMID:19859722 DOI:10.1007/s00384-009-0814-z]
13 Law WL,Choi HK,Chu KW.Comparison of stenting with emergency surgery as palliative treatment for obstructing primary left-sided colorectal cancer.Br J Surg 2003;90:1429-1433[PMID:14598426 DOI:10.1002/bjs.4311]
14 Fiori E,Lamazza A,De Cesare A,Bononi M,Volpino P,Schillaci A,Cavallaro A,Cangemi V.Palliative management of malignant rectosigmoidal obstruction.Colostomy vs endoscopic stenting.A randomized prospective trial.Anticancer Res 2004;24:265-268[PMID:15015606]
15 Carne PW,Frye JN,Robertson GM,Frizelle FA.Stents or open operation for palliation of colorectal cancer:a retrospective,cohort study of perioperative outcome and long-term survival.Dis Colon Rectum 2004;47:1455-1461[PMID:15486741 DOI:10.1007/s10350-004-0624-x]
16 Tomiki Y,Watanabe T,Ishibiki Y,Tanaka M,Suda S,Yamamoto T,Sakamoto K,Kamano T.Comparison of stent placement and colostomy as palliative treatment for inoperable malignant colorectal obstruction.Surg Endosc 2004;18:1572-1577[PMID:15931483 DOI:10.1007/s00464-004-8106-8]
17 Liang TW,Sun Y,Wei YC,Yang DX.Palliative treatment of malignant colorectal obstruction caused by advanced malignancy:a self-expanding metallic stent or surgery?A system review and meta-analysis.Surg Today 2014;44:22-33[PMID:23893158 DOI:10.1007/s00595-013-0665-7]
18 Sebastian S,Johnston S,Geoghegan T,Torreggiani W,Buckley M.Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction.Am JGastroenterol 2004;99:2051-2057[PMID:15447772 DOI:10.1111/j.1572-0241.2004.40017.x]
19 van Hooft JE,Fockens P,Marinelli AW,Timmer R,van Berkel AM,Bossuyt PM,Bemelman WA;Dutch Colorectal Stent Group.Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer.Endoscopy 2008;40:184-191[PMID:18322873 DOI:10.1055/s-2007-995426]
20 Xinopoulos D,Dimitroulopoulos D,Theodosopoulos T,Tsamakidis K,Bitsakou G,Plataniotis G,Gontikakis M,Kontis M,Paraskevas I,Vassilobpoulos P,Paraskevas E.Stenting or stoma creation for patients with inoperable malignant colonic obstructions?Results of a study and costeffectiveness analysis.Surg Endosc 2004;18:421-426[PMID:14735348 DOI:10.1007/s00464-003-8109-x]
21 Fernández-Esparrach G,Bordas JM,Giráldez MD,Ginès A,PelliséM,Sendino O,Martínez-PallíG,Castells A,Llach J.Severe complications limit long-term clinical success of self-expanding metal stents in patients with obstructive colorectal cancer.Am J Gastroenterol 2010;105:1087-1093[PMID:19935785 DOI:10.1038/ajg.2009.660]
22 Sousa M,Pinho R,Proen?a L,Silva J,Ponte A,Rodrigues J,Carvalho J.Predictors of Complications and Mortality in Patients with Self-Expanding Metallic Stents for the Palliation of Malignant Colonic Obstruction.GE Port J Gastroenterol 2017;24:122-128[PMID:28848796 DOI:10.1159/000452697]
23 Imbulgoda A,MacLean A,Heine J,Drolet S,Vickers MM.Colonic perforation with intraluminal stents and bevacizumab in advanced colorectal cancer:retrospective case series and literature review.Can J Surg 2015;58:167-171[PMID:25799132 DOI:10.1503/cjs.013014]
24 van Halsema EE,van Hooft JE,Small AJ,Baron TH,García-Cano J,Cheon JH,Lee MS,Kwon SH,Mucci-Hennekinne S,Fockens P,Dijkgraaf MG,Repici A.Perforation in colorectal stenting:a meta-analysis and a search for risk factors.Gastrointest Endosc 2014;79:970-982.e7;quiz 983.e2,983.e5[PMID:24650852 DOI:10.1016/j.gie.2013.11.038]
25 Yoon JY,Jung YS,Hong SP,Kim TI,Kim WH,Cheon JH.Outcomes of secondary stent-in-stent self-expandable metal stent insertion for malignant colorectal obstruction.Gastrointest Endosc2011;74:625-633[PMID:21762906 DOI:10.1016/j.gie.2011.05.025]
26 Kuwai T,Yamaguchi T,Imagawa H,Yoshida S,Isayama H,Matsuzawa T,Yamada T,Saito S,Shimada M,Hirata N,Sasaki T,Koizumi K,Maetani I,Saida Y.Factors related to difficult selfexpandable metallic stent placement for malignant colonic obstruction:A post-hoc analysis of a multicenter study across Japan.Dig Endosc 2019;31:51-58[PMID:30113095 DOI:10.1111/den.13260]
27 Yoon JY,Jung YS,Hong SP,Kim TI,Kim WH,Cheon JH.Clinical outcomes and risk factors for technical and clinical failures of self-expandable metal stent insertion for malignant colorectal obstruction.Gastrointest Endosc 2011;74:858-868[PMID:21862005 DOI:10.1016/j.gie.2011.05.044]
28 Manes G,de Bellis M,Fuccio L,Repici A,Masci E,Ardizzone S,Mangiavillano B,Carlino A,Rossi GB,Occhipinti P,Cennamo V.Endoscopic palliation in patients with incurable malignant colorectal obstruction by means of self-expanding metal stent:analysis of results and predictors of outcomes in a large multicenter series.Arch Surg 2011;146:1157-1162[PMID:22006874 DOI:10.1001/archsurg.2011.233]
29 Small AJ,Coelho-Prabhu N,Baron TH.Endoscopic placement of self-expandable metal stents for malignant colonic obstruction:long-term outcomes and complication factors.Gastrointest Endosc 2010;71:560-572[PMID:20189515 DOI:10.1016/j.gie.2009.10.012]
30 Cennamo V,Fuccio L,Mutri V,Minardi ME,Eusebi LH,Ceroni L,Laterza L,Ansaloni L,Pinna AD,Salfi N,Martoni AA,Bazzoli F.Does stent placement for advanced colon cancer increase the risk of perforation during bevacizumab-based therapy?Clin Gastroenterol Hepatol 2009;7:1174-1176[PMID:19631290 DOI:10.1016/j.cgh.2009.07.015]
31 Yoon JY,Park SJ,Hong SP,Kim TI,Kim WH,Cheon JH.Outcomes of secondary self-expandable metal stents versus surgery after delayed initial palliative stent failure in malignant colorectal obstruction.Digestion 2013;88:46-55[PMID:23880524 DOI:10.1159/000351208]
